Christopher James Sampson
Personal Details
First Name: | Christopher |
Middle Name: | James |
Last Name: | Sampson |
Suffix: | |
RePEc Short-ID: | psa1048 |
| |
http://www.chrissampson.me | |
Southside, 7th Floor, 105 Victoria Street, London SW1E 6QT UK | |
+44 (0)20 7747 8866 | |
Terminal Degree: | 2020 (from RePEc Genealogy) |
Affiliation
Office of Health Economics
London, United Kingdomhttp://www.ohe.org/
RePEc:edi:ohecouk (more details at EDIRC)
Research output
Jump to: Working papers ArticlesWorking papers
- David Mott;Gayathri Kumar;Chris Sampson;Martina Garau, 2021. "How is Quality of Life Measured for Health Technology Assessments?," Briefing 002357, Office of Health Economics.
- Chris Sampson;Martina Garau, 2019. "How Should We Measure Quality of Life Impact in Rare Disease? Recent Learnings in Spinal Muscular Atrophy," Briefing 002146, Office of Health Economics.
- Sampson, Christopher & James, Marilyn & Huband, Nick & Geelan, Steve & McMurran, Mary, 2013. "Cost implications of treatment non-completion in a forensic personality disorder service," MPRA Paper 48757, University Library of Munich, Germany.
- Hernández-Alava, Mónica & Sampson, Christopher & Wailoo, Allan, 2013. "Happy and healthy: a joint model of health and life satisfaction," MPRA Paper 49766, University Library of Munich, Germany.
- Sampson, Christopher & James, Marilyn & Whynes, David, 2013.
"The relationship between individual risk and cost-effectiveness in screening interventions,"
MPRA Paper
51799, University Library of Munich, Germany.
repec:ohe:conrep:002047 is not listed on IDEAS
repec:ohe:respap:002308 is not listed on IDEAS
repec:ohe:respap:002040 is not listed on IDEAS
repec:ohe:conrep:001976 is not listed on IDEAS
Articles
- Chris Sampson & Bernarda Zamora & Sam Watson & John Cairns & Kalipso Chalkidou & Patricia Cubi-Molla & Nancy Devlin & Borja García-Lorenzo & Dyfrig A. Hughes & Ashley A. Leech & Adrian Towse, 2022. "Supply-Side Cost-Effectiveness Thresholds: Questions for Evidence-Based Policy," Applied Health Economics and Health Policy, Springer, vol. 20(5), pages 651-667, September.
- Chris Sampson, 2022. "NICE and the EQ-5D-5L: Ten Years Trouble," PharmacoEconomics - Open, Springer, vol. 6(1), pages 5-8, January.
- Chris Sampson & Isobel Firth & Adrian Towse, 2021. "Health Opportunity Costs and Expert Elicitation: A Comment on Soares et al," Medical Decision Making, , vol. 41(3), pages 255-257, April.
- Christopher James Sampson & Renée Arnold & Stirling Bryan & Philip Clarke & Sean Ekins & Anthony Hatswell & Neil Hawkins & Sue Langham & Deborah Marshall & Mohsen Sadatsafavi & Will Sullivan & Edward , 2019. "Transparency in Decision Modelling: What, Why, Who and How?," PharmacoEconomics, Springer, vol. 37(11), pages 1355-1369, November.
- Christopher James Sampson & Tim Wrightson, 2017. "Model Registration: A Call to Action," PharmacoEconomics - Open, Springer, vol. 1(2), pages 73-77, June.
- Christopher Sampson & David Whitehurst & Andrew Street, 2013. "Do patients registered with CAM-trained GPs really use fewer health care resources and live longer? A response to Kooreman and Baars. Eur J Health Econ (2012). 13:469–776," The European Journal of Health Economics, Springer;Deutsche Gesellschaft für Gesundheitsökonomie (DGGÖ), vol. 14(4), pages 703-705, August.
Citations
Many of the citations below have been collected in an experimental project, CitEc, where a more detailed citation analysis can be found. These are citations from works listed in RePEc that could be analyzed mechanically. So far, only a minority of all works could be analyzed. See under "Corrections" how you can help improve the citation analysis.Blog mentions
As found by EconAcademics.org, the blog aggregator for Economics research:- Hernández-Alava, Mónica & Sampson, Christopher & Wailoo, Allan, 2013.
"Happy and healthy: a joint model of health and life satisfaction,"
MPRA Paper
49766, University Library of Munich, Germany.
Mentioned in:
- #HEJC papers for October 2013
by academichealtheconomists in The Academic Health Economists' Blog on 2013-10-01 04:30:26 - Chris Sampson’s journal round-up for 13th March 2017
by Chris Sampson in The Academic Health Economists' Blog on 2017-03-13 17:00:42
- #HEJC papers for October 2013
- Christopher James Sampson & Renée Arnold & Stirling Bryan & Philip Clarke & Sean Ekins & Anthony Hatswell & Neil Hawkins & Sue Langham & Deborah Marshall & Mohsen Sadatsafavi & Will Sullivan & Edward , 2019.
"Transparency in Decision Modelling: What, Why, Who and How?,"
PharmacoEconomics, Springer, vol. 37(11), pages 1355-1369, November.
Mentioned in:
- Chris Sampson’s journal round-up for 9th March 2020
by Chris Sampson in The Academic Health Economists' Blog on 2020-03-09 12:00:00
- Chris Sampson’s journal round-up for 9th March 2020
- Sampson, Christopher & James, Marilyn & Whynes, David, 2013.
"The relationship between individual risk and cost-effectiveness in screening interventions,"
MPRA Paper
51799, University Library of Munich, Germany.
Mentioned in:
- New working paper – ‘The relationship between individual risk and cost-effectiveness in screening interventions’
by Chris Sampson in Chris Sampson on 2013-12-03 12:00:55 - Thesis Thursday: Chris Sampson
by captaincanaway in The Academic Health Economists' Blog on 2020-08-20 06:00:04
- New working paper – ‘The relationship between individual risk and cost-effectiveness in screening interventions’
- Christopher James Sampson & Tim Wrightson, 2017.
"Model Registration: A Call to Action,"
PharmacoEconomics - Open, Springer, vol. 1(2), pages 73-77, June.
Mentioned in:
- Meeting round-up: Health Economists’ Study Group (HESG) Winter 2018
by Chris Sampson in The Academic Health Economists' Blog on 2018-01-19 07:00:03 - Chris Sampson’s journal round-up for 1st April 2019
by Chris Sampson in The Academic Health Economists' Blog on 2019-04-01 11:00:21
- Meeting round-up: Health Economists’ Study Group (HESG) Winter 2018
- Chris Sampson;Martina Garau, 2019.
"How Should We Measure Quality of Life Impact in Rare Disease? Recent Learnings in Spinal Muscular Atrophy,"
Briefing
002146, Office of Health Economics.
Mentioned in:
- Chris Sampson’s journal round-up for 7th September 2020
by Chris Sampson in The Academic Health Economists' Blog on 2020-09-07 11:00:07
- Chris Sampson’s journal round-up for 7th September 2020
- Author Profile
- 10 steps to open access success
by Chris Sampson in Chris Sampson on 2015-10-21 10:00:10
- 10 steps to open access success
Working papers
- Chris Sampson;Martina Garau, 2019.
"How Should We Measure Quality of Life Impact in Rare Disease? Recent Learnings in Spinal Muscular Atrophy,"
Briefing
002146, Office of Health Economics.
Cited by:
- Amanda Whittal & Michela Meregaglia & Elena Nicod, 2021. "The Use of Patient-Reported Outcome Measures in Rare Diseases and Implications for Health Technology Assessment," The Patient: Patient-Centered Outcomes Research, Springer;International Academy of Health Preference Research, vol. 14(5), pages 485-503, September.
Articles
- Chris Sampson & Isobel Firth & Adrian Towse, 2021.
"Health Opportunity Costs and Expert Elicitation: A Comment on Soares et al,"
Medical Decision Making, , vol. 41(3), pages 255-257, April.
Cited by:
- Marta O. Soares & Mark J. Sculpher & Karl Claxton, 2021. "Authors’ Response to: “Health Opportunity Costs and Expert Elicitation: A Comment on Soares et al.†by Sampson, Firth, and Towse," Medical Decision Making, , vol. 41(3), pages 258-260, April.
- Christopher James Sampson & Renée Arnold & Stirling Bryan & Philip Clarke & Sean Ekins & Anthony Hatswell & Neil Hawkins & Sue Langham & Deborah Marshall & Mohsen Sadatsafavi & Will Sullivan & Edward , 2019.
"Transparency in Decision Modelling: What, Why, Who and How?,"
PharmacoEconomics, Springer, vol. 37(11), pages 1355-1369, November.
Cited by:
- Kai Jia & Nan Zhang, 2022. "Categorization and eccentricity of AI risks: a comparative study of the global AI guidelines," Electronic Markets, Springer;IIM University of St. Gallen, vol. 32(1), pages 59-71, March.
- Harvard, Stephanie & Werker, Gregory R. & Silva, Diego S., 2020. "Social, ethical, and other value judgments in health economics modelling," Social Science & Medicine, Elsevier, vol. 253(C).
- Josh J. Carlson & Surrey M. Walton & Anirban Basu & Richard H. Chapman & Jonathan D. Campbell & R. Brett McQueen & Steven D. Pearson & Daniel R. Touchette & David Veenstra & Melanie D. Whittington & D, 2019. "Achieving Appropriate Model Transparency: Challenges and Potential Solutions for Making Value-Based Decisions in the United States," PharmacoEconomics, Springer, vol. 37(11), pages 1321-1327, November.
- Christopher James Sampson & Tim Wrightson, 2017.
"Model Registration: A Call to Action,"
PharmacoEconomics - Open, Springer, vol. 1(2), pages 73-77, June.
Cited by:
- Emma McManus & David Turner & Tracey Sach, 2019. "Can You Repeat That? Exploring the Definition of a Successful Model Replication in Health Economics," PharmacoEconomics, Springer, vol. 37(11), pages 1371-1381, November.
- Hannah Christensen & Hareth Al-Janabi & Pierre Levy & Maarten J. Postma & David E. Bloom & Paolo Landa & Oliver Damm & David M. Salisbury & Javier Diez-Domingo & Adrian K. Towse & Paula K. Lorgelly & , 2020.
"Economic evaluation of meningococcal vaccines: considerations for the future,"
The European Journal of Health Economics, Springer;Deutsche Gesellschaft für Gesundheitsökonomie (DGGÖ), vol. 21(2), pages 297-309, March.
- Hannah Christensen & Hareth Al-Janabi & Pierre Lévy & Maarten J. Postma & David E. Bloom & Paolo Landa & David M. Salisbury & Javier Diez-Domingo & Adrian K. Towse & Paula K. Lorgelly & Koonal K. Shah, 2020. "Economic evaluation of meningococcal vaccines: considerations for the future," Post-Print hal-03120553, HAL.
- Philip Clarke & John Buckell & Adrian Barnett, 2020. "Registered Reports: Time to Radically Rethink Peer Review in Health Economics," PharmacoEconomics - Open, Springer, vol. 4(1), pages 1-4, March.
- Renée J. G. Arnold & Sean Ekins, 2017. "Ahead of Our Time: Collaboration in Modeling Then and Now," PharmacoEconomics, Springer, vol. 35(9), pages 975-976, September.
More information
Research fields, statistics, top rankings, if available.Statistics
Access and download statistics for all items
Co-authorship network on CollEc
List Editorship
This author manages the following RePEc Biblio topics, reading lists or publication compilations:Featured entries
This author is featured on the following reading lists, publication compilations, Wikipedia, or ReplicationWiki entries:NEP Fields
NEP is an announcement service for new working papers, with a weekly report in each of many fields. This author has had 9 papers announced in NEP. These are the fields, ordered by number of announcements, along with their dates. If the author is listed in the directory of specialists for this field, a link is also provided.- NEP-HEA: Health Economics (8) 2013-08-31 2013-09-28 2013-12-06 2018-05-21 2018-10-08 2019-03-25 2020-12-07 2021-07-19. Author is listed
- NEP-INO: Innovation (2) 2018-10-08 2018-10-15
- NEP-COM: Industrial Competition (1) 2018-10-15
- NEP-HAP: Economics of Happiness (1) 2013-09-28
- NEP-HIS: Business, Economic & Financial History (1) 2018-10-08
- NEP-TID: Technology & Industrial Dynamics (1) 2018-10-15
- NEP-UPT: Utility Models & Prospect Theory (1) 2020-12-07
Corrections
All material on this site has been provided by the respective publishers and authors. You can help correct errors and omissions. For general information on how to correct material on RePEc, see these instructions.
To update listings or check citations waiting for approval, Christopher James Sampson should log into the RePEc Author Service.
To make corrections to the bibliographic information of a particular item, find the technical contact on the abstract page of that item. There, details are also given on how to add or correct references and citations.
To link different versions of the same work, where versions have a different title, use this form. Note that if the versions have a very similar title and are in the author's profile, the links will usually be created automatically.
Please note that most corrections can take a couple of weeks to filter through the various RePEc services.